CLINICAL_TRIALS ClinicalTrials.gov record update

A Clinical Safety and Efficacy Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Head and Neck Cancer

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT05830240
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:39:12.231804+00:00
Published At: 2023-04-26T00:00:00+00:00
Record Updated At: 2023-04-26
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Head and Neck Cancer", "Esophageal Cancer", "Otorhinolaryngologic Neoplasms", "Ear Cancer", "Nose Cancer", "Laryngeal Cancer", "Pharyngeal Cancer"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2023-04-26"
protocolSection.identificationModule.nctId: "NCT05830240"
protocolSection.identificationModule.officialTitle: "A Clinical Safety and Efficacy Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Head and Neck Cancer"
protocolSection.statusModule.overallStatus: "UNKNOWN"
protocolSection.designModule.phases: ["EARLY_PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.